Drug Trial Radar · NCT06305234
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Last checked: Nov 20, 2026Latest source record: Mar 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jan 20, 2024
Primary completion
Nov 18, 2033
Study completion Nov 18, 2033
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Mar 12, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 10-year multi-center, prospective, longitudinal, single arm study evaluating immunologic, inflammatory and laboratory parameters associated with long-term Palynziq treatment in subjects with phenylketonuria (PKU) in the United States (US). Subjects in the US for whom a clinical decision has been made that they will receive pegvaliase to treat their PKU within 30 days following the date of enrollment in Study 165-501 (incident-users) or who have previously started treatment with pegvaliase at the date of enrollment in Study 165-501 (prevalent-users) are eligible for participation in Study 165-503.
Conditions
- Phenylketonuria (PKU)
Interventions
PegvaliaseDrug
Must be enrolled in the 165-501 PALace study. Subjects currently receiving or who plan to receive pegvaliase treatment within 30 days after the date of enrollment in the 165-501 study, including subjects who previously received pegvaliase as part of the clinical development program and have completed study participation
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate immunologic and inflammatory responses associated with occurrences ofTime frame: A maximum of 10 years treatment duration.
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
University of Colorado
Aurora, Colorado · Recruiting
Emory University
Atlanta, Georgia · Recruiting
Northwestern University
Chicago, Illinois · Recruiting
Riley Children's Hospital/ Indiana University Health
Indianapolis, Indiana · Recruiting
Tulane University School of Medicine
New Orleans, Louisiana · Recruiting
Boston Children's Hospital
Boston, Massachusetts · Recruiting
Oregon Health & Science University
Portland, Oregon · Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Recruiting
Vanderbilt University Medical School
Nashville, Tennessee · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
Children's Wisconsin/Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.